BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38385385)

  • 21. Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management.
    Myint TM; Chong CHY; Wyld M; Nankivell B; Kable K; Wong G
    Transplantation; 2022 Jan; 106(1):e76-e89. PubMed ID: 33908382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection.
    Boonyapredee M; Knight K; Little D
    Mil Med; 2014 Jun; 179(6):e699-702. PubMed ID: 24902140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic and therapeutic dilemma of the co-existence of BK virus nephropathy with acute rejection - an experience from a single Centre and review of the literature.
    Shanmugham S; Bhadauria D; Agrawal V; Jain M; Yaccha M; Kaul A; Vamsidhar V; Meyyappan J; Prasad N
    Transpl Immunol; 2022 Jun; 72():101581. PubMed ID: 35301106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monthly screening for polyoma virus eliminates BK nephropathy and preserves renal function.
    Petrov R; Elbahloul O; Gallichio MH; Stellrecht K; Conti DJ
    Surg Infect (Larchmt); 2009 Feb; 10(1):85-90. PubMed ID: 19298172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
    Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopsy-Proven BK Virus-Associated Nephropathy: Clinico-Pathologic Correlations.
    Jahdali S; Al Oudah N; Alsaad KO; Kfoury H; Qurashi S; Al Sayyari A
    Exp Clin Transplant; 2017 Jun; 15(3):289-294. PubMed ID: 28137206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
    Keller N; Duquennoy S; Conrad A; Fafi-Kremer S; Morelon E; Bouvier N; Moulin B; Hurault De Ligny B; Caillard S
    Transpl Infect Dis; 2019 Apr; 21(2):e13058. PubMed ID: 30730102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability in assessing for BK viremia: whole blood is not reliable and plasma is not above reproach - a retrospective analysis.
    Agrawal N; Echenique IA; Meehan SM; Limaye AP; Cook L; Chang A; Harland RC; Javaid B; Kadambi PV; Matushek S; Williams J; Josephson MA
    Transpl Int; 2017 Jul; 30(7):670-678. PubMed ID: 28295760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.
    Tohme FA; Kalil RS; Thomas CP
    Transpl Infect Dis; 2015 Feb; 17(1):66-72. PubMed ID: 25582442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
    Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
    Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
    Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose steroid therapy in BK viremia adversely affected the long-term graft function after kidney transplantation.
    Kim H; Yu H; Baek CH; Han DJ; Park SK
    Transpl Infect Dis; 2016 Dec; 18(6):844-849. PubMed ID: 27622599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of intravenous immunoglobulin in a highly sensitized pediatric renal transplant recipient with severe BK DNAemia and rising DSA.
    Piburn KH; Al-Akash S
    Pediatr Transplant; 2020 Feb; 24(1):e13600. PubMed ID: 31657100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late-onset BK viral nephropathy in a kidney transplant recipient.
    Mathew JC; Holanda DG; Figanbaum TL; Fraer M; Thomas CP
    Transplant Proc; 2014 Sep; 46(7):2386-90. PubMed ID: 25242792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.
    Drachenberg CB; Papadimitriou JC; Chaudhry MR; Ugarte R; Mavanur M; Thomas B; Cangro C; Costa N; Ramos E; Weir MR; Haririan A
    Am J Transplant; 2017 Aug; 17(8):2078-2091. PubMed ID: 28422412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of polyomavirus nephropathy in renal transplant patients: a single-center experience.
    Kojc N; Aleš Rigler A; Mlinšek G; Kovač D; Ferluga D; Arnol M
    Clin Nephrol; 2017 Supplement 1; 88(13):109-114. PubMed ID: 28655392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.